tirzepatide approved by fda approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly's weight-loss pill is
Description
PLoS ONE 2016,11, e0168396
For botanical compounds with oral bioavailability challenges, transdermal delivery may offer advantages - that's the scientific rationale the brand draws on
These spikes may be followed by drops that leave you hungry again, which goes against the appetite-control effect tirzepatide is supposed to help with
First, it tells your brain that you are full
That means Tirzepatide mimics the action of two hormones at once, GLP-1 and GIP, which is why its gaining attention as a potentially more effective option for glycemic control
